Evan Loh's Insider Trades & SAST Disclosures
Evan Loh's most recent trade in Paratek Pharmaceuticals Inc. was a trade of 168,750 Common Stock done . Disclosure was reported to the exchange on Aug. 8, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Evan Loh.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2023 | 168,750 | 1,376,948 (3%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.20 per share. | 08 Aug 2023 | 48,967 | 1,327,981 (3%) | 0% | 2.2 | 107,727 | Common Stock |
| Eiger BioPharmaceuticals Inc | Evan Loh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2022 | 52,500 | 1,231,687 (3%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.99 per share. | 20 Dec 2022 | 23,489 | 1,208,198 (3%) | 0% | 2.0 | 46,743 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 12 Dec 2022 | 61,919 | 1,179,187 (2%) | 0% | 2.0 | 121,361 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 1.98 per share. | 12 Dec 2022 | 37,831 | 1,241,106 (3%) | 0% | 2.0 | 74,905 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 28 Oct 2022 | 8,805 | 1,278,937 (3%) | 0% | 3.5 | 30,553 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 30,000 | 1,287,742 (3%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 152,727 | 1,302,261 (3%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 08 Aug 2022 | 44,519 | 1,257,742 (3%) | 0% | 2.7 | 118,421 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 236,250 | 1,149,534 (2%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 4.27 per share. | 13 Dec 2021 | 49,259 | 913,284 (2%) | 0% | 4.3 | 210,336 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 4.37 per share. | 13 Dec 2021 | 23,834 | 962,543 (2%) | 0% | 4.4 | 104,155 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 4.42 per share. | 13 Dec 2021 | 13,983 | 986,377 (2%) | 0% | 4.4 | 61,805 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 75,000 | 1,034,291 (2%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 16 Aug 2021 | 33,931 | 1,000,360 (2%) | 0% | 5.1 | 173,727 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 91,636 | 995,945 (2%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 9.70 per share. | 27 May 2021 | 36,654 | 959,291 (2%) | 0% | 9.7 | 355,544 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 303,750 | 904,309 (2%) | 0% | 0 | Common Stock | |
| Eiger BioPharmaceuticals Inc | Evan Loh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Eiger BioPharmaceuticals Inc | Evan Loh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 5,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Eiger BioPharmaceuticals Inc | Evan Loh | Director | Sale of securities on an exchange or to another person at price $ 10.14 per share. | 12 Mar 2021 | 2,000 | 8,000 (0%) | 0% | 10.1 | 20,280 | Common Stock |
| Windtree Therapeutics Inc | Evan Loh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 6.71 per share. | 11 Dec 2020 | 26,415 | 600,559 (1%) | 0% | 6.7 | 177,245 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 6.95 per share. | 11 Dec 2020 | 18,585 | 626,974 (1%) | 0% | 7.0 | 129,166 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2020 | 75,000 | 666,487 (1%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Sale of securities on an exchange or to another person at price $ 5.93 per share. | 12 Nov 2020 | 20,928 | 645,559 (1%) | 0% | 5.9 | 124,103 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 29 Oct 2020 | 39,479 | 591,487 (1%) | 0% | 4.3 | 169,760 | Common Stock |
| Paratek Pharmaceuticals Inc. | Evan Loh | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2020 | 39,479 | 0 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges